ZEISS India launches 'Specslounge.com' an omni-channel e-commerce platform for its business partners

The website goes under the name https://www.specslounge.com/.

As a brand that remains focused on B2B operations, with the latest omni-channel ecommerce platform, aims to strengthen its partnership with opticians while adapting to the evolving digital landscape. The new platform will enable end-consumers to order both frames and lenses with ease, offering a convenient and streamlined solution for their businesses and customers.

Commenting on the launch, Rohan Paul, Head of Vision Care at ZEISS India and Neighboring Markets said, “We remain committed to enabling our business partners in their pursuit of doing successful business. Integrating digital solutions in overall purchase journey is a step to empower our business partners (opticians) to better serve their customers, allowing them the flexibility to choose where and when to buy - be it online or in-store.”

“The newly launched platform does not change ZEISS’s core B2B model. Instead, it acts as a lead generation and sales enhancement tool for opticians, enabling them to expand their reach and attract new customers while maintaining strong relationships with existing ones.”, Rohan Paul further added.

ZEISS India affirms that opticians will continue to play a crucial role as the primary point of contact for end-consumers. Beyond product sales, opticians will provide essential services such as eye tests, frame fittings, and expert consultations. This ensures that the personalized customer experience remains intact, even as digital accessibility increases.

For more information about the new ZEISS omni-channel e-commerce platform please visit: https://www.specslounge.com/

About ZEISS
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue around 11 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (30 September 2024).

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 15 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.

With over 46,000 employees, ZEISS is active globally in around 50 countries with more than 60 sales and service locations, around 40 research and development facilities, and 35 production facilities worldwide (30 September 2024). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Further information at www.zeiss.com